Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Systemic treatments for mesothelioma: standard and novel.

Kindler HL.

Curr Treat Options Oncol. 2008 Jun;9(2-3):171-9. doi: 10.1007/s11864-008-0071-3. Epub 2008 Sep 3. Review.

2.

Malignant pleural mesothelioma.

Kindler HL.

Curr Treat Options Oncol. 2000 Oct;1(4):313-26. Review.

PMID:
12057157
3.

Patterns of failure following surgical resection for malignant pleural mesothelioma.

Jänne PA, Baldini EH.

Thorac Surg Clin. 2004 Nov;14(4):567-73. Review.

PMID:
15559064
4.

Pemetrexed: a multitargeted antifolate.

Rollins KD, Lindley C.

Clin Ther. 2005 Sep;27(9):1343-82. Review.

PMID:
16291410
5.

Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation.

Dundar Y, Bagust A, Dickson R, Dodd S, Green J, Haycox A, Hill R, McLeod C, Walley T.

Health Technol Assess. 2007 Jan;11(1):1-90. Review.

6.

The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive review.

Boons CC, VAN Tulder MW, Burgers JA, Beckeringh JJ, Wagner C, Hugtenburg JG.

Anticancer Res. 2013 Sep;33(9):3553-61. Review.

PMID:
24023280
7.

The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.

Ellis P, Davies AM, Evans WK, Haynes AE, Lloyd NS; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care..

J Thorac Oncol. 2006 Jul;1(6):591-601. Review.

8.

Overview on ongoing or planned clinical trials in Europe.

Favaretto A.

Lung Cancer. 2005 Jul;49 Suppl 1:S117-21. Epub 2005 Apr 9. Review.

PMID:
15950791
9.
10.

Malignant pleural mesothelioma.

Chen SE, Pace MB.

Am J Health Syst Pharm. 2012 Mar 1;69(5):377-85. doi: 10.2146/ajhp110281. Review.

PMID:
22345416
11.

Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma.

Manegold C.

Semin Oncol. 2003 Aug;30(4 Suppl 10):32-6. Review.

PMID:
12917819
12.

Pemetrexed for diffuse malignant pleural mesothelioma.

Manegold C, Aisner J.

Semin Oncol. 2002 Apr;29(2 Suppl 5):30-5. Review.

PMID:
12023790
13.

Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma.

Green J, Dundar Y, Dodd S, Dickson R, Walley T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005574. Review.

PMID:
17253564
14.

Pemetrexed in malignant pleural mesothelioma.

Gatzemeier U.

Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):26-31. Review.

15.

Combined chemotherapy with cytotoxic and targeted compounds for the management of human malignant pleural mesothelioma.

Favoni RE, Florio T.

Trends Pharmacol Sci. 2011 Aug;32(8):463-79. doi: 10.1016/j.tips.2011.03.011. Epub 2011 May 26. Review.

PMID:
21620489
16.

Emerging insights into the biology and therapy of malignant mesothelioma.

Vogelzang NJ.

Semin Oncol. 2002 Dec;29(6 Suppl 18):35-42. Review.

PMID:
12571809
17.

Chemotherapy and targeted therapies for unresectable malignant mesothelioma.

Kelly RJ, Sharon E, Hassan R.

Lung Cancer. 2011 Sep;73(3):256-63. doi: 10.1016/j.lungcan.2011.04.014. Epub 2011 May 28. Review.

18.

The emerging role of pemetrexed for the treatment of malignant mesothelioma.

Kindler HL.

Oncology (Williston Park). 2004 Jul;18(8 Suppl 5):49-53. Review.

19.

Second-line treatment for malignant pleural mesothelioma.

Ceresoli GL, Zucali PA, Gianoncelli L, Lorenzi E, Santoro A.

Cancer Treat Rev. 2010 Feb;36(1):24-32. doi: 10.1016/j.ctrv.2009.09.003. Epub 2009 Oct 29. Review.

PMID:
19879055
20.

FDA drug approval summaries: pemetrexed (Alimta).

Hazarika M, White RM, Johnson JR, Pazdur R.

Oncologist. 2004;9(5):482-8. Review.

Supplemental Content

Support Center